CMND - CIK 0001892500
The table below shows Clearmind Medicine Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $640.49K | $723.05K | $451.86K | $461.44K | $345.88K | $322.96K |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $3.02M |
| $684.72K |
| $855.12K |
| $1.03M |
| $1.13M |
| $980.55K |
| Operating income | - | - | - | - | - | - |
| Income tax | - | - | - | - | - | - |
| Net income | - | - | - | - | - | - |
| EPS (diluted) | - | - | - | - | - | - |